[ Price : $8.95]
FDA accepts for priority review a Precigen BLA for PRGN-2012 (zopapogene imadenovec), an investigational adenoverse gene therapy f...[ Price : $8.95]
FDA lifts a 12/2022-ordered clinical hold on Entrada Therapeutics Duchenne muscular dystrophy therapy ENTR-601-44 and provided aut...[ Price : $8.95]
Former CDER director Patrizia Cavazzoni rejoins Pfizer as the companys chief medical officer.[ Price : $8.95]
FDA approves a Medtronic PMA for its BrainSense Adaptive deep brain stimulation and BrainSense Electrode Identifier for use in Par...[ Price : $8.95]
FDA moves over the weekend to rehire up to 300 scientists and reviewers who were terminated last week as part of the Trump Adminis...[ Price : $8.95]
FDA tells Insmed that it does not currently plan to hold an advisory committee meeting to discuss the companys NDA for brensocatib...[ Price : $8.95]
FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Opdivo (nivolumab) plus Yervoy (ipilimumab) for a firs...[ Price : $8.95]
Drug compounding operations sue FDA in northern Texas federal court, seeking an order to reverse the agency decision last week to ...